Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- 2000 liver cancer patients studied to uncover best Pre-Surgery treatments Results expected Dec 2026 (estimated)
- Office-Based blood pressure program aims to tame hypertension in young workers Results expected Jan 2027 (estimated)
-
Immunotherapy plus chemo shows promise against tough throat cancer
Disease control OngoingThis phase 2 trial tests whether adding a PD-1 inhibitor (a type of immunotherapy) to standard chemotherapy before radiation can improve outcomes for people with advanced nasopharyngeal carcinoma. About 150 participants will receive either the combination or chemotherapy alone, f…
Phase 2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI could spot liver cancer types and predict survival without needle biopsy
Diagnosis OngoingThis study is developing an artificial intelligence system that combines CT/MRI scans, lab results, and radiology reports to help diagnose liver cancer and predict how patients will fare after surgery. The AI aims to distinguish benign from malignant liver lesions and differentia…
Sponsor: Guangxi Medical University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
AI could slash unnecessary prostate biopsies in 'Gray Zone' patients
Diagnosis OngoingThis study tests an artificial intelligence system that combines blood tests, lab data, and ultrasound images to better diagnose prostate cancer in men with borderline PSA levels (4-10 ng/mL). The goal is to reduce unnecessary biopsies by accurately identifying who truly has canc…
Sponsor: Guangxi Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
AI could predict which prostate cancers turn aggressive
Knowledge-focused OngoingThis study is developing an artificial intelligence model to predict which patients with advanced prostate cancer are at higher risk of developing a more severe form called castration-resistant prostate cancer. The AI will analyze MRI images, biopsy slides, and clinical data from…
Sponsor: Guangxi Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC